|

RAD301 ([68Ga]-RAD301) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Radiopharm Theranostics, Ltd1

Indications

  • Healthy Volunteers1
  • Pancreatic Ductal Adenocarcinoma1
  • Esophageal Squamous Cell Carcinoma1
  • Non-small Cell Lung Cancer (NSCLC)1
  • Endometrial Cancer1

Princeton, New Jersey1 trial

Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors

United Theranostics

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.